In early 2015, the White House announced a $215 million initiative aimed at making precision medicine a priority in healthcare, using tools like big data analytics and advances in genome research to personalize treatments and patient care. However, results from a recent survey suggest most healthcare organizations are not on board and don't expect to be anytime soon.
The survey was conducted by Health Catalyst and queried CIOs, CMIOs and CMOs of health systems. Notable findings included:
- 59 percent of respondents said precision medicine will not play a significant role in their organization in the next five years.
- 68 percent of respondents said precision medicine will play a non-existent, small or average role in their organizations between now and 2020.
- 63 percent of respondents said their organizations had no plans to integrate genomic data into their EHRs, although 50 percent agree genomic data could have a positive impact on their patient treatment strategies.
- 71 percent of respondents from academic medical centers said precision medicine would play a significant role in their organizations in the next five years.
- 64 percent of respondents from academic medical centers they plan to integrate genomic data into their EHRs.